Study of Intravenous TCD-717 in Patients With Advanced Solid Tumors

NCT01215864 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: TCD-717

Sponsor

Traslational Cancer Drugs Pharma, SL